Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases-Reference-Cited by-同舟云学术

Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases

Published:2009-01-08 Issue:4 Volume:23 Page:673-678
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Itzykson R, ,Ayari S,Vassilief D,Berger E,Slama B,Vey N,Suarez F,Beyne-Rauzy O,Guerci A,Cheze S,Thomas X,Stamatoullas A,Gardembas M,Bauduer F,Kolb A,Chaury M C,Legros L,Damaj G,Chermat F,Dreyfus F,Fenaux P,Ades L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2008362.pdf

Reference36 articles.

1. Hellstrom-Lindberg E, Malcovati L . Supportive care, growth factors, and new therapies in myelodysplastic syndromes. Blood Rev 2008; 22: 75–91.

2. Steensma DP, Tefferi A . Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc 2007; 82: 958–966.

3. Malcovati L . Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. Leuk Res 2007; 31 (Suppl 3): S2–S6.

4. Casadevall N, Durieux P, Dubois S, Hemery F, Lepage E, Quarre MC et al. Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood 2004; 104: 321–327.

5. Jadersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellstrom-Lindberg E . Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 2005; 106: 803–811.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia;Frontiers in Pharmacology;2024-07-04

2. Targeting the Microenvironment in MDS: The Final Frontier;Frontiers in Pharmacology;2020-07-09

3. Decitabine Compared With Conventional Regimens in Older Patients With Acute Myeloid Leukemia: A Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2019-12

4. Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years;Blood Advances;2019-09-19

5. miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin;Molecular Therapy;2019-03